AHP GINK

Each monograph establishes national standards for assuring authenticity, purity, and quality control of the monographed botanical. Accompanying the standards is the AHP Therapeutic Compendium which provides a complete and critical review of the pharmacological and safety data currently available, including information on pharmacokinetics, pharmacodynamics, actions, medical indications, historical and modern and traditional use, structure and function claims, dosages, interactions, side effects, contraindications, toxicology, and more.Ginkgo leaf is used by many for its reported effects on improving cognitive functions. According to AHP Executive Director Roy Upton, " Between 1975 and 2002, more than 40 controlled trials were published concerning the use of ginkgo leaf extract to treat patients with cerebrovascular insufficiency. The overwhelming majority of the available studies report positive findings such as improved cognition and even a slow down in the progression of Alzheimer's. Management and treatment of Alzheimer's patients is one of the greatest drains on Medicare costs and costs the US in excess of $100 billion annually. This latter benefit alone could save hundreds of millions in health care costs." Table of Contents:

• Nomenclature
• History
• Identificaton
• Commercial Sources and Handling
• Consitutents
• Analytical
• Therapeutics
• Safety Profile
• International Status
• References

Product Details

Published:

01/01/2003

ISBN(s):

1929425171

Number of Pages:

77

File Size:

1 file , 1.1 MB